Haddad_2022_Health.Psychol.Res_10_31925

Reference

Title : Aducanumab, a Novel Anti-Amyloid Monoclonal Antibody, for the Treatment of Alzheimer's Disease: A Comprehensive Review - Haddad_2022_Health.Psychol.Res_10_31925
Author(s) : Haddad HW , Malone GW , Comardelle NJ , Degueure AE , Kaye AM , Kaye AD
Ref : Health Psychol Res , 10 :31925 , 2022
Abstract : Haddad_2022_Health.Psychol.Res_10_31925
ESTHER : Haddad_2022_Health.Psychol.Res_10_31925
PubMedSearch : Haddad_2022_Health.Psychol.Res_10_31925
PubMedID: 35928986

Related information

Citations formats

Haddad HW, Malone GW, Comardelle NJ, Degueure AE, Kaye AM, Kaye AD (2022)
Aducanumab, a Novel Anti-Amyloid Monoclonal Antibody, for the Treatment of Alzheimer's Disease: A Comprehensive Review
Health Psychol Res 10 :31925

Haddad HW, Malone GW, Comardelle NJ, Degueure AE, Kaye AM, Kaye AD (2022)
Health Psychol Res 10 :31925